And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, once again, rather modest. We plan to catch up on our reading, promenade with the official mascot, and take a few naps. And what about you? Given recent disturbing events, this may be a good time to take a long constitutional (pun intended) and clear your head. You could boost the economy by purchasing another sweater or wooly socks. Or touch base with someone feeling isolated. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you on Tuesday, since we have an extended break on this side of the pond. …

President-elect Joe Biden has chosen David Kessler to help lead Operation Warp Speed, the program to accelerate development of Covid-19 vaccines and treatments, The New York Times reports. Kessler, a pediatrician and lawyer who headed the Food and Drug Administration during the presidencies of George Bush and Bill Clinton, has been a key adviser to Biden on Covid-19 policy and is co-chair of the transition team’s Covid-19 task force. He will replace Moncef Slaoui, who will become a consultant to Operation Warp Speed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Source: STATNEWS.COM

Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]